Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Renard

Showing results (91-100 of 225) with videos related to

Pageof 23
Sort By:
Acta Diabetologica|October 24, 2020
Assessment of the effect of pregnancy planning in women with type 1 diabetes treated by insulin pumpLucie Mourou, Valeria Vallone, Eleonora Vania, et al.
Frontiers in Psychiatry|June 3, 2021
Effects of Hormonal Contraception Use on Cognitive Functions in Patients With Bulimia NervosaBenedicte Nobile, Laurent Maimoun, Isabelle Danielle Jaussent, et al.
Journal of Diabetes|April 17, 2014
Glycemic control after 6 days of insulin pump reservoir use in type 1 diabetes: results of double-blind and open-label cross-over trials of insulin lispro and insulin aspartWilliam V Tamborlane, Eric Renard, R Paul Wadwa, et al.
Journal of Abnormal Psychology|October 11, 2019
Structural differences in eating disorder psychopathology after history of childhood abuse: Insights from a Bayesian network analysisRachel F Rodgers, Russell DuBois, Sylvain Thiebaut, et al.
Scientific Reports|October 7, 2022
Definition of an adapted cut-off for determining low lean tissue mass in older women with obesity: a comparison to current cut-offsLaurent Maïmoun, Chris Serrand, Thibault Mura, et al.
Diabetes, Obesity & Metabolism|March 4, 2017
Lixisenatide reduces glycaemic variability in insulin-treated patients with type 2 diabetesGuillermo E Umpierrez, David O'Neal, Andres DiGenio, et al.
Diabetes Technology & Therapeutics|March 3, 2022
RESCUE Collaborative Community: A New Initiative to Reduce Rates of Intended Self-Injury and Suicide Among People with DiabetesKatharine D Barnard, Shideh Majidi, Mark A Clements, et al.
Diabetes, Obesity & Metabolism|October 20, 2022
Continuous glucose monitoring-based time-in-range using insulin glargine 300 units/ml versus insulin degludec 100 units/ml in type 1 diabetes: The head-to-head randomized controlled InRange trialTadej Battelino, Thomas Danne, Steve V Edelman, et al.
Diabetes, Obesity & Metabolism|December 27, 2024
Minimum expectations for market authorization of continuous glucose monitoring devices in Europe-'eCGM' compliance statusChantal Mathieu, Concetta Irace, Emma G Wilmot, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 12, 2021
Root cause determination of intraperitoneal catheter obstructions: Insulin amyloid aggregates vs foreign body reactionJia He, Eric Renard, Peter Lord, et al.
Pageof 23

Showing results (91-100 of 225) with videos related to

Sort By:
Pageof 23
Acta Diabetologica|October 24, 2020
Assessment of the effect of pregnancy planning in women with type 1 diabetes treated by insulin pumpLucie Mourou, Valeria Vallone, Eleonora Vania, et al.
Frontiers in Psychiatry|June 3, 2021
Effects of Hormonal Contraception Use on Cognitive Functions in Patients With Bulimia NervosaBenedicte Nobile, Laurent Maimoun, Isabelle Danielle Jaussent, et al.
Journal of Diabetes|April 17, 2014
Glycemic control after 6 days of insulin pump reservoir use in type 1 diabetes: results of double-blind and open-label cross-over trials of insulin lispro and insulin aspartWilliam V Tamborlane, Eric Renard, R Paul Wadwa, et al.
Journal of Abnormal Psychology|October 11, 2019
Structural differences in eating disorder psychopathology after history of childhood abuse: Insights from a Bayesian network analysisRachel F Rodgers, Russell DuBois, Sylvain Thiebaut, et al.
Scientific Reports|October 7, 2022
Definition of an adapted cut-off for determining low lean tissue mass in older women with obesity: a comparison to current cut-offsLaurent Maïmoun, Chris Serrand, Thibault Mura, et al.
Diabetes, Obesity & Metabolism|March 4, 2017
Lixisenatide reduces glycaemic variability in insulin-treated patients with type 2 diabetesGuillermo E Umpierrez, David O'Neal, Andres DiGenio, et al.
Diabetes Technology & Therapeutics|March 3, 2022
RESCUE Collaborative Community: A New Initiative to Reduce Rates of Intended Self-Injury and Suicide Among People with DiabetesKatharine D Barnard, Shideh Majidi, Mark A Clements, et al.
Diabetes, Obesity & Metabolism|October 20, 2022
Continuous glucose monitoring-based time-in-range using insulin glargine 300 units/ml versus insulin degludec 100 units/ml in type 1 diabetes: The head-to-head randomized controlled InRange trialTadej Battelino, Thomas Danne, Steve V Edelman, et al.
Diabetes, Obesity & Metabolism|December 27, 2024
Minimum expectations for market authorization of continuous glucose monitoring devices in Europe-'eCGM' compliance statusChantal Mathieu, Concetta Irace, Emma G Wilmot, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 12, 2021
Root cause determination of intraperitoneal catheter obstructions: Insulin amyloid aggregates vs foreign body reactionJia He, Eric Renard, Peter Lord, et al.
Pageof 23